OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
07/23/2026
Back to search
Official data from USPTO
ROSUVASOME
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
07/23/2026
Trademark type
Word
Nice classes
5
Filing date
11/25/2024
Registration date
03/17/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/17/2026
Last transaction
07/23/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
CN
Examiner
MANCA, ALBERTO I
Law office
L80
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
BEIJING INNO MEDICINE CO., LTD.
Representatives
Joseph R. Dages Gray Ice Higdon, PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicines for human purposes for the treatment of cardiovascular diseasescoronary artery diseasecerebrovascular diseasesperipheral vascular diseasescoronary atherosclerotic diseaseerectile dysfunctioncognition impairment; medical cardiovascular pharmaceuticals; cardiovascular pharmaceuticals; pharmaceuticals for the treatment of cardiovascular and cerebrovascular diseases; capsules sold empty for medicines; pharmaceutical preparations for the treatment of cardiovascular diseasescoronary artery diseasecerebrovascular diseasesperipheral vascular diseasescoronary atherosclerotic diseaseerectile dysfunctioncognition impairment; pharmaceuticals for medical purposes for the treatment of cardiovascular diseasescoronary artery diseasecerebrovascular diseasesperipheral vascular diseasescoronary atherosclerotic diseaseerectile dysfunctioncognition impairment; ointments for pharmaceutical purposesantibiotic ointmentsanti-inflammatory ointment; biological preparations for medical purposes for the treatment of cardiovascular diseasescoronary artery diseasecerebrovascular diseasesperipheral vascular diseasescoronary atherosclerotic diseaseerectile dysfunctioncognition impairment; chemical preparations for medical purposes for the treatment of cardiovascular diseasescoronary artery diseasecerebrovascular diseasesperipheral vascular diseasescoronary atherosclerotic diseaseerectile dysfunctioncognition impairment
Publications
History of USPTO decisions and trademark events.
22 publications found
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/06/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
07/05/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/17/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/17/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
03/17/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/27/2026
PUBO
PUBLISHED FOR OPPOSITION
01/27/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/21/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/02/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/09/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/09/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/09/2025
RFNT
REFUSAL PROCESSED BY IB
08/02/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/17/2025
RFRR
REFUSAL PROCESSED BY MPU
07/16/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/24/2025
CNRT
NON-FINAL ACTION WRITTEN
05/23/2025
DOCK
ASSIGNED TO EXAMINER
05/16/2025
MAFR
APPLICATION FILING RECEIPT MAILED
02/08/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/08/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/06/2025
Continuous trademark protection
Get notified about every new filing that threatens ROSUVASOME or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.